TY - JOUR
T1 - Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry
AU - Danek, Barbara A.
AU - Karatasakis, Aris
AU - Alame, Aya J.
AU - Nguyen-Trong, Phuong Khanh J
AU - Karacsonyi, Judit
AU - Rangan, Bavana
AU - Roesle, Michele
AU - Atwell, Amy
AU - Resendes, Erica
AU - Martinez-Parachini, Jose Roberto
AU - Iwnetu, Rahel
AU - Kalsaria, Pratik
AU - Siddiqui, Furqan
AU - Muller, James E.
AU - Banerjee, Subhash
AU - Brilakis, Emmanouil
N1 - Publisher Copyright:
© 2016 Wiley Periodicals, Inc.
PY - 2017/5
Y1 - 2017/5
N2 - Objectives: We sought to examine near-infrared spectroscopy (NIRS) imaging findings of aortocoronary saphenous vein grafts (SVGs). Background: SVGs are prone to develop atherosclerosis similar to native coronary arteries. They have received little study using NIRS. Methods: We examined the clinical characteristics and imaging findings from 43 patients who underwent NIRS imaging of 45 SVGs at our institution between 2009 and 2016. Results: The mean patient age was 67 ± 7 years and 98% were men, with high prevalence of diabetes mellitus (56%), hypertension (95%), and dyslipidemia (95%). Mean SVG age was 7 ± 7 years, mean SVG lipid core burden index (LCBI) was 53 ± 60 and mean maxLCBI4 mm was 194 ± 234. Twelve SVGs (27%) had lipid core plaques (2 yellow blocks on the block chemogram), with a higher prevalence in SVGs older than 5 years (46% vs. 5%, P = 0.002). Older SVG age was associated with higher LCBI (r = 0.480, P < 0.001) and higher maxLCBI4 mm (r = 0.567, P < 0.001). On univariate analysis, greater annual total cholesterol exposure was associated with higher SVG LCBI (r = 0.30, P = 0.042) and annual LDL-cholesterol and triglyceride exposure were associated with higher SVG maxLCBI4 mm (LDL-C: r = 0.41, P = 0.020; triglycerides: r = 0.36, P = 0.043). On multivariate analysis, the only independent predictor of SVG LCBI and maxLCBI4mm was SVG age. SVG percutaneous coronary intervention was performed in 63% of the patients. An embolic protection device was used in 96% of SVG PCIs. Periprocedural myocardial infarction occurred in one patient. Conclusions: Older SVG age and greater lipid exposure are associated with higher SVG lipid burden.
AB - Objectives: We sought to examine near-infrared spectroscopy (NIRS) imaging findings of aortocoronary saphenous vein grafts (SVGs). Background: SVGs are prone to develop atherosclerosis similar to native coronary arteries. They have received little study using NIRS. Methods: We examined the clinical characteristics and imaging findings from 43 patients who underwent NIRS imaging of 45 SVGs at our institution between 2009 and 2016. Results: The mean patient age was 67 ± 7 years and 98% were men, with high prevalence of diabetes mellitus (56%), hypertension (95%), and dyslipidemia (95%). Mean SVG age was 7 ± 7 years, mean SVG lipid core burden index (LCBI) was 53 ± 60 and mean maxLCBI4 mm was 194 ± 234. Twelve SVGs (27%) had lipid core plaques (2 yellow blocks on the block chemogram), with a higher prevalence in SVGs older than 5 years (46% vs. 5%, P = 0.002). Older SVG age was associated with higher LCBI (r = 0.480, P < 0.001) and higher maxLCBI4 mm (r = 0.567, P < 0.001). On univariate analysis, greater annual total cholesterol exposure was associated with higher SVG LCBI (r = 0.30, P = 0.042) and annual LDL-cholesterol and triglyceride exposure were associated with higher SVG maxLCBI4 mm (LDL-C: r = 0.41, P = 0.020; triglycerides: r = 0.36, P = 0.043). On multivariate analysis, the only independent predictor of SVG LCBI and maxLCBI4mm was SVG age. SVG percutaneous coronary intervention was performed in 63% of the patients. An embolic protection device was used in 96% of SVG PCIs. Periprocedural myocardial infarction occurred in one patient. Conclusions: Older SVG age and greater lipid exposure are associated with higher SVG lipid burden.
KW - lipids
KW - saphenous vein bypass graft
KW - saphenous vein graft interventions
UR - http://www.scopus.com/inward/record.url?scp=84994469254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994469254&partnerID=8YFLogxK
U2 - 10.1002/ccd.26696
DO - 10.1002/ccd.26696
M3 - Article
C2 - 27535486
AN - SCOPUS:84994469254
SN - 1522-1946
VL - 89
SP - E172-E180
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
IS - 6
ER -